Skip to content

Efficacy of a Brain-Computer Interface Controlled Functional Electrical Stimulation Therapy for Spinal Cord Injury Neurorehabilitation

Efficacy of a Therapy With Brain-Computer Interface Controlled Functional Electrical Stimulation for Neurorehabilitation of Patients With Spinal Cord Injury (Eficacia de Una Terapia Con estimulación eléctrica Funcional Controlada Con Interfaz Cerebro-computadora Para neurorrehabilitación de Pacientes Con lesión Medular)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05343130
Enrollment
32
Registered
2022-04-25
Start date
2022-08-01
Completion date
2027-12-31
Last updated
2025-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spinal Cord Injury

Keywords

brain-computer interface, functional electrical stimulation, motor rehabilitation, tetraplegia

Brief summary

The study's main goal is to determine the efficacy of a therapy with brain-computer interface controlled functional electrical stimulation for neurorehabilitation of spinal cord injury patients' upper limbs. For this purpose, a randomized controlled trial will be performed to compare the clinical and physiological effects of the brain-computer interface therapy with those of a sham intervention comprised by the application of functional electrical stimulation independently of brain-computer interface control.

Interventions

Hand movement will be elicited using functional electrical stimulation activated by the brain-computer interface based on hand movement intention.

Hand movement will be elicited using functional electrical stimulation which activation will be independent of the brain-computer interface based on hand movement intention.

Sponsors

Instituto Tecnologico y de Estudios Superiores de Monterey
CollaboratorOTHER
Instituto Nacional de Rehabilitacion
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Spinal Cord Injury at neurological levels C6 or C7 * American Spinal Injury Association (ASIA) classification A, B, C or D * Upper limb spasticity of less or equal to +1 measured with the Modified Ashworth Scale * Time since disease onset of more than 6 months and less than 60 months * Normal or corrected to normal vision

Exclusion criteria

* Severe attention deficits * Previous diagnosis of traumatic brain injury * Previous diagnosis of peripheral nerve injury * Previous stroke diagnosis * Previous diagnosis of neurodegenerative diseases * History of fractures in upper extremities * Skin lesions * Contractures in upper extremities that hamper mobility * Excessive muscle spasms

Design outcomes

Primary

MeasureTime frameDescription
Action Research Arm Test (ARAT)At enrollment and after 7 weeks of the intervention onsetChange of upper limbs function. Scale ranges from 0 to 57 points for each upper limb. A higher score means a better upper limb function.
Upper Extremity Motor Score (UEMS)At enrollment and after 7 weeks of the intervention onsetChange of upper limbs function. Scale ranges from 0 to 50 points if both upper limbs are assessed. A higher score means a better upper limb function.
Capabilities of Upper Extremities Questionnaire (CUE-Q)At enrollment and after 7 weeks of the intervention onsetChange of the functional limitation in tetraplegia. Scale ranges from 32 to 224 points if both upper limbs are assessed. A higher score means less functional limitation outcome.

Secondary

MeasureTime frameDescription
Spinal Cord Independence Measure III (SCIM-III)At enrollment and after 7 weeks of the intervention onsetChange of achievements of daily function. Scale ranges from 0 to 100 points. A higher score means a better capacity to perform activities of the daily living.
Life Satisfaction Questionnaire 9 (LISAT-9)At enrollment and after 7 weeks of the intervention onsetChange of life satisfaction. Scale ranges from 0 to 54 points. A higher score is expected with a better life satisfaction.

Countries

Mexico

Contacts

Primary ContactJessica Cantillo-Negrete, PhD
jcantillo@inr.gob.mx+525559991000
Backup ContactRuben I Carino-Escobar, PhD
ricarino@inr.gob.mx+525559991000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026